第13巻 2017年10月　第4号

■特集〔動脈硬化症　基礎から臨床へ〕

虚血性心疾患の臨床
黒部　裕嗣¹, 佐田　政隆^2
1徳島大学大学院医歯薬学研究部心臓血管外科学分野
²徳島大学大学院医歯薬学研究部循環器内科学分野

Ischemic Heart Disease -from Clinical Side-
Hirotsugu Kurobe¹ and Masataka Sata^2
1)Department of Cardiovascular Surgery, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan
²⁾Department of Cardiovascular Medicine, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

Over 190,000 patients die each year in japan due to ischemic heart disease. For these patients, percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) are done to improve the blood flow of coronary artery with stenosis. It would be better to prevent or mitigate the progress of atherosclerosis in these patients before requiring surgery. Recently, it has been reported that epicardial adipose tissue plays an important role in the progression of atherosclerosis and ischemic heart disease.
This review shows the recent trends about ischemic heart disease from the clinical perspective, including its' treatment, pathology and preventive measure.

日医大医会誌 2017; 13(4), 210-213

Key words
epicardial adipose tissue, ischemic heart disease, CABG, biodegradable device

Correspondence to
Hirotsugu Kurobe, MD, PhD, Department of Cardiovascular Surgery, Graduate School of Biomedical Sciences, Tokushima University, 3-8-15 Kuramoto-chou, Tokushima-shi TOKUSHIMA 770-8503, JAPAN
E-mail：hirotsugu.kurobe@tokushima-u.ac.jp

受付：2017年9月4日　受理：2017年9月11日